Viewing Study NCT00689156


Ignite Creation Date: 2025-12-24 @ 11:14 PM
Ignite Modification Date: 2025-12-25 @ 8:50 PM
Study NCT ID: NCT00689156
Status: COMPLETED
Last Update Posted: 2018-04-05
First Post: 2008-05-29
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Epirubicin or Not in Patients With TOP2A (Topoisomerase (DNA) II Alpha (170kD)) Normal Early Breast Cancer
Sponsor: Danish Breast Cancer Cooperative Group
Organization: